Health Idea Now
Thursday, 20 December 2018
Gilead, Agenus sign deal to develop immuno-oncology therapies
Gilead Sciences Inc has inked a collaboration agreement with Agenus Inc for the development and marketing of up to five novel immuno-oncology therapies.
from Reuters: Health News https://ift.tt/2BvkREk
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment